NORTHERN IRELAND is the sponsor country for day two of Arab Health.
World-class Life & Health Sciences Companies & Universities share their expertise and experience delivering innovative research, products and services.
Northern Ireland business sessions will be held at the business forum adjacent to the dealers and distributors lounge at Za'abeel Hall 4.
Register for FREE to attend the sessions.
Northern Ireland.
Connected, Collaborative, Commercialised.
This event is now closed. Check in with us on the Arab Health website in the coming months, to see what we have in store for next year.
Organisation | Speaker | Topic | Time |
Armstrong Medical | Stephen Moore Business Development Executive |
POINT (Peri Operative Insufflatory Nasal Therapy) & Flowkit | 2.00-2.10 |
Biopanda Reagents Ltd | Philip McKee Sales Manager, MENA |
Vitro diagnostics for clinical, veterinary and food safety markets | 2.15-2.25 |
Clonallon Laboratories Ltd | Edward Henry Clinical Director |
The Clonallon value proposition- procedure packs and medical supplies | 2.30-2.40 |
Clinisent | Dr Ahmad Ghazzawi General Manager Clinisent MENA |
Patient Driven Care |
2.45-2.55 |
Paradox Omega Oils Ltd | Geoff Hayhurst Director |
Innovative, unique high-quality Omega fatty acid food supplements for all the family | 3.00-3.10 |
TriMedika Ltd | Dr Roisin Molloy CEO |
Save $$millions, optimise infection control and connect your hospital with a simple hand-held device from a UK manufacturer | 3.15-3.25 |
Ulster University | Professor David Hassan Associate Dean (Global Engagement) for the Faculty of Life and Health Sciences |
World-class education and training programmes in the fields of Life and Health Sciences | 3.30.3.40 |
CIGA Healthcare | Robert Grundy CEO |
Suresign - A Family of Rapid Point of Care Diagnostic Products for the OTC Market | 3.45-3.55 |
CIS Oncology | David Allcock | How a specialist medical oncology work-flow and complimentary EMR application can benefit patient outcomes, clinician efficiency, and cost. | 4.00-4.10 |
Elemental Software |
Jennifer Neff Co-CEO |
A practical approach to prevention with social prescribing at the core |
4.15-4.25 |